Form 4: Director Kathleen Winters Receives RSU Grant at DH

Definitive Healthcare Corp. director Kathleen A. Winters was granted 189,190 restricted stock units as part of annual equity compensation.

Summary

• Director Kathleen A. Winters acquired 189,190 restricted stock units (RSUs) of Definitive Healthcare Corp. (DH) Class A Common Stock.
• The transaction occurred on June 4, 2026.
• The RSUs represent a contingent right to receive one share of Class A Common Stock per unit.
• Following this transaction, the reporting person's total beneficial ownership increased to 308,982 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of immediate market impact.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.
• Increased equity stake for a member of the board of directors.

Negatives

• Potential for future dilution of existing shareholders upon the vesting and settlement of these RSUs.

Risks

• Vesting is subject to the reporting person's continued service through the vesting date.
• Market volatility affecting the future value of the underlying Class A Common Stock.

Future Outlook

The RSUs are scheduled to vest on June 4, 2027, or the date of the next annual meeting of stockholders, provided the director remains in service.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practice to ensure board alignment with shareholder interests in the healthcare technology sector.

Comparison to Industry Standards

• The grant of RSUs as part of director compensation is consistent with standard practices for publicly traded SaaS and healthcare technology companies.
• The vesting schedule of one year is typical for annual director equity awards.

Stakeholder Impact

• Shareholders may experience minor dilution upon the eventual vesting and issuance of the underlying shares.

Next Steps

• Vesting of the RSUs on June 4, 2027, or the date of the next annual meeting.

Key Dates

Keywords

Definitive Healthcare, DH, Form 4, Insider Trading, Equity Compensation, Restricted Stock Units